Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton’s tyrosine kinase inhibitorTherapeutics Published on 2023-08-252024-09-04 Journal: Multiple Sclerosis Journal [Category] 대상포진, [키워드] Bruton’s tyrosine kinase COVID-19 Evobrutinib multiple sclerosis SARS-CoV-2 Vaccines [DOI] 10.1177/13524585231192460 PMC 바로가기 [Article Type] Therapeutics
Observations on the use of Bruton’s tyrosine kinase inhibitors in SAR-CoV-2 and cancerSAR-CoV-2 및 암에서 Bruton의 티로신 키나제 억제제 사용에 대한 관찰Letter to the Editor Published on 2021-01-132022-09-10 Journal: Journal of Hematology & Oncology [Category] 신약개발, 유전자 메커니즘, [키워드] Acalabrutinib acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Bruton’s tyrosine kinase BTK BTK inhibitor Cancer circulation Coronavirus-2 COVID-19 COVID-19 patient COVID-19 patients Cytokines determine drug Ibrutinib IL-1β infected with SARS-CoV-2 inhibitors innate immune system Lung disease Lung injury observation Patient potential mechanism pro-inflammatory cytokine pro-inflammatory cytokines PROTECT pulmonary injury respiratory SAR-CoV-2 SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus tyrosine tyrosine kinase inhibitor understanding [DOI] 10.1186/s13045-020-00999-8 PMC 바로가기 [Article Type] Letter to the Editor
Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib TreatmentCase Report Published on 2019-08-222023-08-29 Journal: Pathogens [Category] E형 간염, [키워드] Bruton’s tyrosine kinase chronification hepatitis E virus Ibrutinib Immunosuppression lymphoplasmacytic lymphoma [DOI] 10.3390/pathogens8030129 PMC 바로가기 [Article Type] Case Report